Cleland JGF, Butler J, Januzzi JL Jr, Pellicori P, et al. Only people with increased plasma concentrations of natriuretic peptides should be included in outcome trials of diabetes, cardiovascular and kidney disease: implications for clinical practice. Eur J Heart Fail 2022;24:678-680.
PMID: 35297132